Allison M Jeynes-Ellis
CIK 1758521 · View on SEC EDGAR ↗
First SEC filing: Dec. 27, 2019 · Latest: Dec. 27, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2024 | AGEN | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 8, 2023 | AGEN | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2022 | AGEN | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 16, 2021 | AGEN | M | 16,853 | — | — | 66,176 Direct | +34.17% | Acquired | (price as of 2026-08-21) |
| June 15, 2021 | AGEN | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 24, 2019 | AGEN | A | 75,000 | — | — | 75,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 19, 2019 | AGEN | A | 20,338 | — | — | 20,338 Direct | — | Acquired | (price as of 2026-08-21) |
| June 19, 2019 | AGEN | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 7, 2018 | AGEN | A | 75,000 | — | — | 75,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 7, 2018 | AGEN | A | 28,985 | — | — | 28,985 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 5, 2024 | AGEN | Stock Option | Common Stock (5,000) | $12.60 | Feb. 5, 2034 | 5,000 | Acquired |
| Jan. 8, 2023 | AGEN | Stock Option | Common Stock (100,000) | $2.40 | Jan. 8, 2033 | 100,000 | Acquired |
| Feb. 4, 2022 | AGEN | Stock Option (Right to Buy) | Common Stock (100,000) | $2.39 | Feb. 4, 2032 | 100,000 | Acquired |
| June 15, 2021 | AGEN | Stock Option | Common Stock (100,000) | $3.18 | Dec. 17, 2030 | 100,000 | Acquired |
| Dec. 24, 2019 | AGEN | Stock Option (Right to buy) | Common Stock (75,000) | $4.12 | Dec. 24, 2029 | 75,000 | Acquired |
| June 19, 2019 | AGEN | Restricted Stock Unit | Common Stock (20,338) | — | — | 20,338 | Acquired |
| June 19, 2019 | AGEN | Stock Option, Right to buy | Common Stock (50,000) | $2.38 | Jan. 1, 2029 | 50,000 | Acquired |
| Nov. 7, 2018 | AGEN | Stock Option (right to buy) | Common Stock (75,000) | $2.07 | Nov. 7, 2027 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).